Affiliation:
1. Department of Cardiology, Pan‐Vascular Research Institute, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China
2. Aab Cardiovascular Research Institute and Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY
Abstract
Background
Vascular smooth muscle cell proliferation, migration, and dedifferentiation are critical for vascular diseases. Recently, it was demonstrated that Notch receptors have opposing effects on intima formation after vessel injury. Therefore, it is important to investigate the specific regulatory pathways that activate the different Notch receptors.
Methods and Results
There was a time‐ and dose‐dependent activation of Notch1 by angiotensin
II
and platelet‐derived growth factor in vascular smooth muscle cells. When phospholipase Cγ1 (
PLC
γ1) expression was reduced by small interfering RNA, Notch1 activation and Hey2 expression (Notch target gene) induced by angiotensin
II
or platelet‐derived growth factor were remarkably inhibited, while Notch2 degradation was not affected. Mechanistically, we observed an association of
PLC
γ1 and Akt, which increased after angiotensin
II
or platelet‐derived growth factor stimulation.
PLC
γ1 knockdown significantly inhibited Akt activation. Importantly,
PLC
γ1 phospholipase site mutation (no phospholipase activity) did not affect Akt activation. Furthermore,
PLC
γ1 depletion inhibited platelet‐derived growth factor–induced vascular smooth muscle cell proliferation, migration, and dedifferentiation, while it increased apoptosis. In vivo,
PLC
γ1 and control small interfering RNA were delivered periadventitially in pluronic gel and complete carotid artery ligation was performed. Morphometric analysis 21 days after ligation demonstrated that
PLC
γ1 small interfering RNA robustly attenuated intima area and intima/media ratio compared with the control group.
Conclusions
PLC
γ1‐Akt–mediated Notch1 signaling is crucial for intima formation. This effect is attributable to
PLC
γ1‐Akt interaction but not
PLC
γ1 phospholipase activity. Specific inhibition of the
PLC
γ1 and Akt interaction will be a promising therapeutic strategy for preventing vascular remodeling.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献